Caring for the Sexual Health and Wellbeing of Cancer Survivors and Their Intimate Partners: An Anonymous Survey

October 6, 2023 updated by: Bournemouth University

An Anonymous Survey Investigating Care for the Sexual Health of Cancer Survivors and Their Intimate Partners, as Provided by the United Kingdom Hospital Cancer Team

The aim of this survey study is to provide broad information as reported by cancer survivors and their intimate partners about both their sexual health and their experiences of care from the United Kingdom hospital cancer team, including their perspectives on factors that may hinder or help care. This information will be analysed and used to inform the questions asked in a separate, subsequent, qualitative study.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

169

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Dorset
      • Bournemouth, Dorset, United Kingdom, BH8 8AJ
        • Bournemouth University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

People with cancer or the partners of people with cancer

Description

Inclusion Criteria:

  1. Cancer survivors diagnosed with any type of cancer at age 18 years or over
  2. A partner of someone diagnosed with any type of cancer at age 18 years or over
  3. Cancer diagnosis must be no more than 10 years ago
  4. Cancer survivors or their partners who experienced treatment and follow up care in the United Kingdom

Exclusion Criteria:

  1. Cancer survivors who were diagnosed with cancer below the age of 18 years
  2. Partners of cancer survivors who were diagnosed with cancer below the age of 18 years
  3. Cancer diagnosis was more than 10 years ago
  4. Cancer survivors/partners of survivors where the cancer treatment and follow up was not in the United Kingdom
  5. Previous completion of the survey

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
People with Cancer
No intervention
No intervention
Partners of People with Cancer
No intervention
No intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants who had a sexual health discussion(s) with the hospital cancer team at any point during cancer care
Time Frame: Up to 10 years prior to completing survey (discussion(s) about sexual health could have occurred at any point during cancer care)
Sexual health discussion:19 examples of the sort of topics that may have been discussed in relation to sexual health
Up to 10 years prior to completing survey (discussion(s) about sexual health could have occurred at any point during cancer care)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with specific levels of impact on their sex lives by cancer and its treatments
Time Frame: From each individual participants' cancer diagnosis/cancer treatment until the date that they completed the survey
As above
From each individual participants' cancer diagnosis/cancer treatment until the date that they completed the survey
Survey questionnaire to measure the nature and prevalence of care for sexual health that cancer survivors and their intimate partners self-report experiencing from the UK hospital cancer team.
Time Frame: Participants can report care received from prior to their cancer treatment through to their follow-up care (last 10 years only)
An online survey questionnaire (no validated questionnaire available and therefore research created the questionnaire based on a literature reviews on sexual health in oncology
Participants can report care received from prior to their cancer treatment through to their follow-up care (last 10 years only)
Survey questionnaire to measure the nature and prevalence of the perceived barriers to and facilitators for care for sexual health as received by cancer survivors and their intimate partners when provided by the UK hospital cancer team.
Time Frame: Participants can report their perceptions from diagnosis through to their follow-up care (last 10 years only)
As above
Participants can report their perceptions from diagnosis through to their follow-up care (last 10 years only)
Survey questionnaire to measure to what extent groups of cancer survivors and their intimate partners with differing characteristics receive differing care for their sexual health from the UK hospital cancer team.
Time Frame: Participants diagnosed with cancer in the previous 10 years.
Participants' responses from outcomes 1-4 will be used toinform this outcome
Participants diagnosed with cancer in the previous 10 years.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 23, 2022

Primary Completion (Actual)

September 30, 2022

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

August 3, 2023

First Submitted That Met QC Criteria

October 6, 2023

First Posted (Estimated)

October 10, 2023

Study Record Updates

Last Update Posted (Estimated)

October 10, 2023

Last Update Submitted That Met QC Criteria

October 6, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Participant information sheet stated that information would not be made publicly available via a data sharing repository. This approach was taken due to the sensitive nature of the topic and was anticipated to provide reassurance and potentially improve recruitment.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on No intervention

3
Subscribe